已收录 268922 条政策
 政策提纲
  • 暂无提纲
Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial
[摘要] In western populations irritable bowel syndrome (IBS) affects between 10% and 30% of the population and has a significant effect on quality of life. It generates a substantial workload in both primary and secondary care and has significant cost implications. Gut-directed hypnotherapy has been demonstrated to alleviate symptoms and improve quality of life but has not been assessed outside of secondary and tertiary referral centres.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 卫生学
[关键词] hypnotherapy;irritable bowel syndrome;randomised controlled trial [时效性] 
   浏览次数:9      统一登录查看全文      激活码登录查看全文